Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
International Journal of Cardiology|May 19, 2006
Long-term versus intermediate-term supervised exercise training in advanced heart failure: effects on exercise tolerance and mortalityAlexander Tenenbaum, Dov Freimark, Ella Ahron, et al.
Cardiovascular Diabetology|June 21, 2008
Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?Alexander Tenenbaum, Valentina Boyko, Enrique Z Fisman, et al.
Cardiovascular Diabetology|April 2, 2023
Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2Alexander Kogan, Avishay Grupper, Avi Sabbag, et al.
Atherosclerosis|September 15, 2006
Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetesHelena Tenenbaum, Solomon Behar, Valentina Boyko, et al.
American Heart Journal|March 27, 2007
Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery diseaseAlexander Tenenbaum, Yehuda Adler, Valentina Boyko, et al.
Cardiovascular Diabetology|August 16, 2017
Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failureOsnat Itzhaki Ben Zadok, Ran Kornowski, Ilan Goldenberg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 30, 2006
Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin levelAki Hiuge, Alexander Tenenbaum, Norikazu Maeda, et al.
Pageof 16